For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Abide Therapeutics, Inc.

USPTO Granted Patents = 18

% Expired Patents = 11.1

CIPO Patents = 2

Forward Citations = 146

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Cheryl A Grice (17 out of 74 patents)

Justin S Cisar (12 out of 22 patents)

Todd Kevin Jones (12 out of 110 patents)

4. Olivia Delene Weber (9 out of 22 patents)

5. Micah J Niphakis (6 out of 11 patents)

6. Benjamin F Cravatt (5 out of 31 patents)

7. Jae Won Chang (4 out of 16 patents)

8. Katharine K Duncan (4 out of 11 patents)

9. Dong-Hui Wang (4 out of 4 patents)

10. Daniel J Buzard (3 out of 41 patents)

11. John J M Wiener (3 out of 28 patents)

12. Kenneth M Lum (3 out of 11 patents)

13. Nicole Suzanne White (2 out of 9 patents)

14. Michael B Shaghafi (2 out of 15 patents)

15. Yu Feng (2 out of 6 patents)

18 patents: Sort by Forward Citations

1. 11129827 - Dual MAGL and FAAH inhibitors (2021-09-28),

2. 11053199 - Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof (2021-07-06),

3. 10350205 - Dual MAGL and FAAH inhibitors (2019-07-16),

4. 10336709 - Lp-PLA2 inhibitors (2019-07-02),

5. 10323038 - Pyrazole compounds and methods of making and using same (2019-06-18),

6. 10266497 - Pyrazole MAGL inhibitors (2019-04-23),

7. 10093635 - MAGL inhibitors (2018-10-09),

8. 10093630 - Pyrazole compounds and methods of making and using same (2018-10-09),

9. 10030020 - Spirocycle compounds and methods of making and using same (2018-07-24),

10. 9994537 - Piperazine carbamates and methods of making and using same (2018-06-12),

11. 9981972 - N-hydroxy bicyclic hydantoin carbamates as tools for identification of serine hydrolase targets (2018-05-29),

12. 9981930 - MAGL inhibitors (2018-05-29),

13. 9957242 - Carbamate compounds and methods of making and using same (2018-05-01),

14. 9828379 - Pyrrolo-pyrrole carbamate and related organic compounds, pharmaceutical compositions, and medical uses thereof (2017-11-28),

15. 9771341 - Piperazine carbamates and methods of making and using same (2017-09-26),

Abide Therapeutics, Inc. is a biotechnology company based in San Diego, California, focused on developing innovative therapeutics for neurological disorders. The company specializes in the discovery and advancement of novel small molecule drugs that target specific enzymes involved in the endocannabinoid system. By leveraging its expertise in medicinal chemistry and pharmacology, Abide aims to address unmet medical needs in conditions such as pain, anxiety, and other neuropsychiatric disorders, contributing to the evolving landscape of cannabinoid-based therapies.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

18 Patents

#328 in San Diego, CA

#4,278 in California

#17,933 in US

#34,146 in the World

San Diego, CA, United States of America

Abide Therapeutics, Inc.

Forward Citations = 146

26 inventors:

Cheryl A Grice (17 out of 74 patents)

Justin S Cisar (12 out of 22 patents)

Todd Kevin Jones (12 out of 110 patents)

4. Olivia Delene Weber (9 out of 22 patents)

5. Micah J Niphakis (6 out of 11 patents)

Please report any incorrect information to [email protected]

Loading…